Caribou Biosciences, Inc. Quarterly Return On Equity in % from Q4 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Caribou Biosciences, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q3 2024.
  • Caribou Biosciences, Inc. Return On Equity for the quarter ending September 30, 2024 was -45.5 %, a 49.8% decline year-over-year.
  • Caribou Biosciences, Inc. annual Return On Equity for 2023 was -31.1 %, a 5.04% decline from 2022.
  • Caribou Biosciences, Inc. annual Return On Equity for 2022 was -29.6 %, a 21.7% increase from 2021.
  • Caribou Biosciences, Inc. annual Return On Equity for 2021 was -37.8 %, a 111% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -45.5 -15.1 -49.8% Jul 1, 2024 Sep 30, 2024
Q2 2024 -34.8 +3.17 +8.36% Apr 1, 2024 Jun 30, 2024
Q1 2024 -33.4 +1.23 +3.55% Jan 1, 2024 Mar 31, 2024
Q4 2023 -31.1 -1.49 -5.04% Oct 1, 2023 Dec 31, 2023
Q3 2023 -30.3 -4.93 -19.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 -37.9 -15.4 -68.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -34.7 -8.54 -32.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -29.6 +8.19 +21.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 -25.4 +59.5 +70.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 -22.6 -192 -113% Apr 1, 2022 Jun 30, 2022
Q1 2022 -26.1 -230 -113% Jan 1, 2022 Mar 31, 2022
Q4 2021 -37.8 -377 -111% Oct 1, 2021 Dec 31, 2021
Q3 2021 -84.9 Jul 1, 2021 Sep 30, 2021
Q2 2021 170 Apr 1, 2021 Jun 30, 2021
Q1 2021 204 Jan 1, 2021 Mar 31, 2021
Q4 2020 340 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.